Open AccessSUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
Author(s) -
David T. Wong,
George N. Lambrou,
Anat Loewenstein,
Ian Pearce,
Annabelle A. Okada
Publication year - 2020
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000002713
Subject(s) - macular degeneration , medicine , vegf receptors , ranibizumab , ophthalmology , degeneration (medical) , drug treatment , vascular endothelial growth factor , surgery , bevacizumab , chemotherapy
To provide guidance on the management of patients with neovascular age-related macular degeneration and its subtypes who respond poorly to anti-vascular endothelial growth factor (anti-VEGF) therapy, and to identify cases where suspending anti-VEGF treatment may be warranted.